Neuralytix Expands iD3 System for Spine Surgery
Fruita, Colorado, August 12, 2026 Neuralytix, LLC announced the full commercial availability of its iD3 System, an FDA 510(k)-cleared...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Fruita, Colorado, August 12, 2026 Neuralytix, LLC announced the full commercial availability of its iD3 System, an FDA 510(k)-cleared...
VANCOUVER, BC, July 30, 2026 Total Flow Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
MONTEREY, Calif., July 29, 2026 Elevation Spine has received U.S. Food and Drug Administration (FDA) 510(k) Clearance for Saber-C®...
ALISO VIEJO, Calif., July 6, 2026 Alcon and RxSight, Inc. have announced a strategic collaboration to jointly develop adjustable...
JERSEY CITY, N.J. and OR YEHUDA, Israel, May 11, 2026 Exero Medical has announced positive pivotal clinical study results...
Dateline – FORT LAUDERDALE, Fla., Feb. 5, 2026 — Spinal Resources Inc. announced that the U.S. Food and Drug...
DALLAS, Texas, September 12, 2025 — Ronovo Surgical has announced the launch of its latest line of advanced surgical...
